-
Je něco špatně v tomto záznamu ?
Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors
J. Skácel, S. Djukic, O. Baszczyňski, F. Kalčic, T. Bílek, K. Chalupský, J. Kozák, A. Dvořáková, E. Tloušt'ová, Z. Král'ová, M. Šmídková, J. Voldřich, M. Rumlová, P. Pachl, J. Brynda, T. Vučková, M. Fábry, J. Snášel, I. Pichová, P. Řezáčová, H....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- inhibitory enzymů * chemie MeSH
- krystalografie MeSH
- lidé MeSH
- purinnukleosidfosforylasa * metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Purine nucleoside phosphorylase (PNP) is a well-known molecular target with potential therapeutic applications in the treatment of T-cell malignancies and/or bacterial/parasitic infections. Here, we report the design, development of synthetic methodology, and biological evaluation of a series of 30 novel PNP inhibitors based on acyclic nucleoside phosphonates bearing a 9-deazahypoxanthine nucleobase. The strongest inhibitors exhibited IC50 values as low as 19 nM (human PNP) and 4 nM (Mycobacterium tuberculosis (Mt) PNP) and highly selective cytotoxicity toward various T-lymphoblastic cell lines with CC50 values as low as 9 nM. No cytotoxic effect was observed on other cancer cell lines (HeLa S3, HL60, HepG2) or primary PBMCs for up to 10 μM. We report the first example of the PNP inhibitor exhibiting over 60-fold selectivity for the pathogenic enzyme (MtPNP) over hPNP. The results are supported by a crystallographic study of eight enzyme-inhibitor complexes and by ADMET profiling in vitro and in vivo.
Faculty of Science Charles University Prague Hlavova 2030 8 Prague 2 12843 Czech Republic
University of Chemistry and Technology Technická 5 Prague 16628 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011377
- 003
- CZ-PrNML
- 005
- 20230801133017.0
- 007
- ta
- 008
- 230718s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.2c02097 $2 doi
- 035 __
- $a (PubMed)37134237
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Skácel, Jan $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 245 10
- $a Design, Synthesis, Biological Evaluation, and Crystallographic Study of Novel Purine Nucleoside Phosphorylase Inhibitors / $c J. Skácel, S. Djukic, O. Baszczyňski, F. Kalčic, T. Bílek, K. Chalupský, J. Kozák, A. Dvořáková, E. Tloušt'ová, Z. Král'ová, M. Šmídková, J. Voldřich, M. Rumlová, P. Pachl, J. Brynda, T. Vučková, M. Fábry, J. Snášel, I. Pichová, P. Řezáčová, H. Mertlíková-Kaiserová, Z. Janeba
- 520 9_
- $a Purine nucleoside phosphorylase (PNP) is a well-known molecular target with potential therapeutic applications in the treatment of T-cell malignancies and/or bacterial/parasitic infections. Here, we report the design, development of synthetic methodology, and biological evaluation of a series of 30 novel PNP inhibitors based on acyclic nucleoside phosphonates bearing a 9-deazahypoxanthine nucleobase. The strongest inhibitors exhibited IC50 values as low as 19 nM (human PNP) and 4 nM (Mycobacterium tuberculosis (Mt) PNP) and highly selective cytotoxicity toward various T-lymphoblastic cell lines with CC50 values as low as 9 nM. No cytotoxic effect was observed on other cancer cell lines (HeLa S3, HL60, HepG2) or primary PBMCs for up to 10 μM. We report the first example of the PNP inhibitor exhibiting over 60-fold selectivity for the pathogenic enzyme (MtPNP) over hPNP. The results are supported by a crystallographic study of eight enzyme-inhibitor complexes and by ADMET profiling in vitro and in vivo.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a purinnukleosidfosforylasa $x metabolismus $7 D011683
- 650 12
- $a inhibitory enzymů $x chemie $7 D004791
- 650 _2
- $a krystalografie $7 D003461
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Djukic, Stefan $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Baszczyňski, Ondřej $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic $u Faculty of Science, Charles University in Prague, Hlavova 2030/8, Prague 2 12843, Czech Republic
- 700 1_
- $a Kalčic, Filip $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic $1 https://orcid.org/0000000243918319
- 700 1_
- $a Bílek, Tadeáš $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Chalupský, Karel $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Kozák, Jaroslav $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Dvořáková, Alexandra $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Tloušt'ová, Eva $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Král'ová, Zuzana $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic $u Faculty of Science, Charles University in Prague, Hlavova 2030/8, Prague 2 12843, Czech Republic
- 700 1_
- $a Šmídková, Markéta $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Voldřich, Jan $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic $u University of Chemistry and Technology, Technická 5, Prague 16628, Czech Republic
- 700 1_
- $a Rumlová, Michaela $u University of Chemistry and Technology, Technická 5, Prague 16628, Czech Republic
- 700 1_
- $a Pachl, Petr $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Brynda, Jiří $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Vučková, Tereza $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Fábry, Milan $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic $u Institute of Molecular Genetics, The Czech Academy of Science, Vídeňská 1083, Prague 14220, Czech Republic
- 700 1_
- $a Snášel, Jan $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Pichová, Iva $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Řezáčová, Pavlína $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Mertlíková-Kaiserová, Helena $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic
- 700 1_
- $a Janeba, Zlatko $u Institute of Organic Chemistry and Biochemistry, The Czech Academy of Sciences, Flemingovo nám. 2, Prague 16610, Czech Republic $1 https://orcid.org/000000034654679X $7 xx0104656
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 66, č. 10 (2023), s. 6652-6681
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37134237 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801133013 $b ABA008
- 999 __
- $a ok $b bmc $g 1963663 $s 1197642
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 66 $c 10 $d 6652-6681 $e 20230503 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20230718